The next generation of evidence-based medicine
V Subbiah - Nature medicine, 2023 - nature.com
Recently, advances in wearable technologies, data science and machine learning have
begun to transform evidence-based medicine, offering a tantalizing glimpse into a future of …
begun to transform evidence-based medicine, offering a tantalizing glimpse into a future of …
Artificial intelligence in drug discovery and development
This chapter comprehensively explores the pivotal role of artificial intelligence (AI) in drug
discovery and development, encapsulating its potentials, methodologies, real-world …
discovery and development, encapsulating its potentials, methodologies, real-world …
A review of the role of artificial intelligence in healthcare
A Al Kuwaiti, K Nazer, A Al-Reedy, S Al-Shehri… - Journal of personalized …, 2023 - mdpi.com
Artificial intelligence (AI) applications have transformed healthcare. This study is based on a
general literature review uncovering the role of AI in healthcare and focuses on the following …
general literature review uncovering the role of AI in healthcare and focuses on the following …
Multimodal machine learning in precision health: A sco** review
Abstract Machine learning is frequently being leveraged to tackle problems in the health
sector including utilization for clinical decision-support. Its use has historically been focused …
sector including utilization for clinical decision-support. Its use has historically been focused …
Artificial intelligence applied to clinical trials: opportunities and challenges
S Askin, D Burkhalter, G Calado, S El Dakrouni - Health and technology, 2023 - Springer
Abstract Background Clinical Trials (CTs) remain the foundation of safe and effective drug
development. Given the evolving data-driven and personalized medicine approach in …
development. Given the evolving data-driven and personalized medicine approach in …
Generative artificial intelligence empowers digital twins in drug discovery and clinical trials
ABSTRACT Introduction The concept of Digital Twins (DTs) translated to drug development
and clinical trials describes virtual representations of systems of various complexities …
and clinical trials describes virtual representations of systems of various complexities …
Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study
Background The existing dementia risk models are limited to known risk factors and
traditional statistical methods. We aimed to employ machine learning (ML) to develop a …
traditional statistical methods. We aimed to employ machine learning (ML) to develop a …
Treatment of pulmonary arterial hypertension: recent progress and a look to the future
M Humbert, O Sitbon, C Guignabert… - The Lancet …, 2023 - thelancet.com
Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …
The coming of age of AI/ML in drug discovery, development, clinical testing, and manufacturing: The FDA Perspectives
SK Niazi - Drug Design, Development and Therapy, 2023 - Taylor & Francis
Artificial intelligence (AI) and machine learning (ML) represent significant advancements in
computing, building on technologies that humanity has developed over millions of years …
computing, building on technologies that humanity has developed over millions of years …
How can machine learning and multiscale modeling benefit ocular drug development?
The eyes possess sophisticated physiological structures, diverse disease targets, limited
drug delivery space, distinctive barriers, and complicated biomechanical processes …
drug delivery space, distinctive barriers, and complicated biomechanical processes …